Back to 
Avoro Capital Advisors LLC
Avoro Capital Advisors LLC
IOVA
Showing 3 of 25 quarters
Position history for Avoro Capital Advisors LLC's holdings in IOVANCE BIOTHERAPEUTICS INC
No. Avoro Capital Advisors exited its IOVA (Iovance Biotherapeutics) position in Q1 2025. Its Q4 2024 13F listed 3,500,000 shares worth $25.9M. Avoro Capital Advisors already held IOVA in its Q1 2019 13F, the earliest on record, and held it in 24 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$39.8M
Total Shares Change
-4.2M
Quarter-by-Quarter History